PSNC: Review of price concessions ‘the priority’ for pharmacy contractors

A review of the price concessions system will take precedent over planned drug reimbursement reforms, PSNC director of pharmacy funding Mike Dent has said.    

price concessions
PSNC needs “to focus [its] energy and effort” on “sorting” out the price concessions system, Mr Dent said

In August, the Pharmaceutical Services Negotiating Committee (PSNC) announced the first of a series of drug reimbursement reforms it had agreed with the government, part of which will see the gradual introduction of a new discount deduction system later this year.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Funding

‘Collective voice’: IPA and NPA pen joint letter over economic review

 
• By 
 • comment

The two pharmacy bodies have urged NHS England (NHSE) to “release immediately” its “long-awaited” economic analysis of community pharmacy, stressing that their “collective voice must be heard”.

GPs ordered to switch on GP Connect by new contract

 
• By 
 • comment

GPs must reinstall GP connect, which allows pharmacies to send routine consultation information to their patients’ GP practices, as part of their £889m-boosted contract, NHS England (NHSE) has revealed.